Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersMedical Oncology Physician in Seattle, WA
NPI: 1366632671Primary Practice Location
EVERGREENHEALTH MONROE
14701 179th Ave Se, Monroe, WA
Primary Employer
University of Washington Physicians
uwmedicine.org
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 125 | 313 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 114 | 163 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 41 | 41 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 19 | 21 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
Authors: Martha Glenn, Elad Ziv, Djordje Atanackovic, Jennifer Caswell-Jin, Alexandra Greenberg
Journal: Nat Commun
Publication Date: 2015-12-09
Authors: Sundararajan Rajkumar, Thomas Martin, Shaji Kumar, Martha Glenn, Elad Ziv, Jeffrey Wolf, Djordje Atanackovic, Jennifer Caswell-Jin, Alexandra Greenberg
Journal: Nat Commun
Publication Date: 2015-07-22
Authors: Carol Huff, Sundararajan Rajkumar, Kenneth Anderson, Michael Lieber, Ajay Nooka, Thomas Martin, Nikhil Munshi, Guido Tricot, Robert Orlowski, Michael Tomasson, Leon Bernal, Sagar Lonial, Ann Mohrbacher, Shaji Kumar, Howard Terebelo, Seema Singhal, Jeffrey Zonder, Sikander Ailawadhi, Martha Glenn,
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Survey Administration, DRUG: Atezolizumab, DRUG: Gemcitabine, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Mitomycin, PROCEDURE: Transurethral Resection of Bladder Tumor, PROCEDURE: Biopsy of Bladder, PROCEDURE: Cystoscopy
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, OTHER: Clinical Observation, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: Cystoscopy, PROCEDURE: CT Urography
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Echocardiography Test, OTHER: Observation Activity
Journal: Cancer Epidemiol Biomarkers Prev
Publication Date: 2016-09-01